Luminex Extends Credit Facility with JP Morgan Chase Through Early 2009 | GenomeWeb
NEW YORK (GenomeWeb News) – Luminex has extended a credit agreement with JP Morgan Chase Bank from last year through February 26, 2009, and has increased the tangible net worth Luminex must maintain to $35 million, according to a filing with the US Securities and Exchange Commission.
 
The agreement extends a credit facility entered into in March 2007, under which the company may borrow up to $15 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.